Schwarzer et al. [1] showed discrepant postfilter ionized calcium concentrations [iCa] when using different blood gas analyzers (BGAs) and called for a change of the Fresenius regional citrate anticoagulation (RCA) protocol to ensure patient safety. Of note, precision of the BGAs was not tested.
In our opinion, the key message of their study is that commercially available BGAs are not accurate when measuring [iCa] outside the reference range and therefore clinicians should avoid using multiple BGAs to guide RCA in individual patients. However, there is no indication to change a RCA protocol which has been proven safe and effective in >10 studies including >2000 patients from different countries regardless of the BGA used [2‐5].
Anzeige
Schwarzer et al. also raise concern about the potential risk of life-threatening citrate intoxication. Whether raised citrate levels are toxic or merely indicative of impaired cellular metabolism remains unclear, but excess citrate can cause metabolic alkalosis. The Fresenius RCA protocol and the technical specifications of the multifiltrate machine both include safety mechanisms to detect potential citrate accumulation early. The risk of citrate toxicity is low (<3 %), even in high-risk patients with liver failure [3, 5].
Given the proven advantages of RCA and the Kidney Disease Improving Global Outcomes (KDIGO) recommendation to use citrate as the first-line anticoagulant during continuous renal replacement therapy, the accuracy of commercially available BGA devices should be improved. In our opinion, there is no need to change a safe and effective protocol.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Competing interests
DKM, MO, and TS have received research grants and funds for speaking at symposia organized on behalf of Fresenius Medical Care, Germany.
Authors’ contributions
All authors were responsible for analysis and interpretation of data, manuscript writing, and final approval of the manuscript.